论文部分内容阅读
慢性丁型肝炎(CHD)是一种病情严重,进展迅速的肝脏疾病,目前尚无有效的治疗方法。为此,作者研究了干扰素α-2a(IFNα-2a)对CHD的疗效。 作者用IFNα-2a观察了42例CHD患者,其方法分为治疗组和对照组,治疗组给予9×10~6U或3×10~6U重组IFNα-2a,每周3次,48周,对照组未给予重组IFN-α-2a。 结果表明,14例接受9×10~6U IFNα-2a治疗后血清ALT恢复正常者10例(71％),
Chronic hepatitis D (CHD) is a serious and rapidly progressing liver disease, and there is no effective treatment. To this end, the authors studied the efficacy of interferon alpha-2a (IFNα-2a) on CHD. The authors used IFNα-2a observed in 42 patients with CHD, the method is divided into treatment group and control group, the treatment group was given 9 × 10 ~ 6U or 3 × 10 ~ 6U recombinant IFNα-2a, 3 times a week, 48 weeks, control Groups were not given recombinant IFN-a-2a. The results showed that in 14 patients receiving 9 × 10 ~ 6U IFNα-2a treatment serum ALT returned to normal in 10 cases (71%),